PFIZER INC. for PFIZER INC.

Health Issues HCR

Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); White House Office

Bills named: S. 3087 (117th), H.R. 3656 (117th), H.R. 3932 (117th)

Medicare/Medicaid MMM

Medicare Part D support for access to treatments for obesity Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of the Vice President of the United States; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); White House Office

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation U.S. Manufacturing Credits Build Back Better Act Minimum Tax

Contacted: SENATE; Treasury, Dept of; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

NAFTA/USMCA Foreign Market Access issues (including IPR) International Supply Chain/Buy America - harmonize international drug manufacturing standards. Global Access to Medicines

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); Commerce, Dept of (DOC); White House Office; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

TRIPS Waiver General IP Issues Bayh-Dole March-In Rights

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); White House Office